Singapore markets closed

Easywell Biomedicals, Inc. (1799.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
130.00+11.50 (+9.70%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 15.84B
Enterprise value 15.75B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)51.42
Price/book (mrq)20.98
Enterprise value/revenue 51.13
Enterprise value/EBITDA -23.15

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 3494.70%
S&P500 52-week change 322.55%
52-week high 3130.00
52-week low 319.68
50-day moving average 388.31
200-day moving average 353.25

Share statistics

Avg vol (3-month) 3410.49k
Avg vol (10-day) 3734k
Shares outstanding 5121.87M
Implied shares outstanding 6123.67M
Float 8118.61M
% held by insiders 156.42%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 426 Jul 2010
Last split factor 2700:1000
Last split date 330 Sept 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -46.83%
Operating margin (ttm)-72.19%

Management effectiveness

Return on assets (ttm)-8.34%
Return on equity (ttm)-23.48%

Income statement

Revenue (ttm)308.08M
Revenue per share (ttm)2.68
Quarterly revenue growth (yoy)98.60%
Gross profit (ttm)N/A
EBITDA -125.55M
Net income avi to common (ttm)-144.28M
Diluted EPS (ttm)-1.23
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)509.3M
Total cash per share (mrq)4.18
Total debt (mrq)417.67M
Total debt/equity (mrq)55.06%
Current ratio (mrq)4.82
Book value per share (mrq)6.20

Cash flow statement

Operating cash flow (ttm)-153.91M
Levered free cash flow (ttm)-130.71M